TP53 c.403_405del ;(p.C135del)

Variant ID: 17-7578525-GGCA-G

NM_000546.5(TP53):c.403_405del;(p.C135del)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell
Hellmann, Matthew D MD; Nathanson, Tavi T; Rizvi, Hira H; Creelan, Benjamin C BC; Sanchez-Vega, Francisco F; Ahuja, Arun A; Ni, Ai A; Novik, Jacki B JB; Mangarin, Levi M B LMB; Abu-Akeel, Mohsen M; Liu, Cailian C; Sauter, Jennifer L JL; Rekhtman, Natasha N; Chang, Eliza E; Callahan, Margaret K MK; Chaft, Jamie E JE; Voss, Martin H MH; Tenet, Megan M; Li, Xue-Mei XM; Covello, Kelly K; Renninger, Andrea A; Vitazka, Patrik P; Geese, William J WJ; Borghaei, Hossein H; Rudin, Charles M CM; Antonia, Scott J SJ; Swanton, Charles C; Hammerbacher, Jeff J; Merghoub, Taha T; McGranahan, Nicholas N; Snyder, Alexandra A; Wolchok, Jedd D JD
Publication Date: 2018-05-14

Variant appearance in text: TP53: C135del
PubMed Link: 29657128
Variant Present in the following documents:
  • mmc3.xlsx, sheet 3
View BVdb publication page



Multiplex amplification coupled with COLD-PCR and high resolution melting enables identification of low-abundance mutations in cancer samples with low DNA content.

The Journal Of Molecular Diagnostics : Jmd
Milbury, Coren A CA; Chen, Clark C CC; Mamon, Harvey H; Liu, Pingfang P; Santagata, Sandro S; Makrigiorgos, G Mike GM
Publication Date: 2011-03

Variant appearance in text: TP53: C135del
PubMed Link: 21354058
Variant Present in the following documents:
  • Main text
View BVdb publication page